ANI Pharmaceuticals Stock Target Price and Analyst Consensus
| ANIP Stock | USD 55.86 0.76 1.38% |
The current analyst and expert consensus on ANI Pharmaceuticals is Buy, with only one strong buy opinion. The current projected ANI Pharmaceuticals target price consensus is 71.67 with 5 analyst opinions. Check out Macroaxis Advice on ANI Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.The most common way ANI Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview ANI Pharmaceuticals executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on ANI Pharmaceuticals. We strongly encourage you to use your own analysis of ANI Pharmaceuticals to validate this buy or sell advice. ANI Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected ANI Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.3464.
Lowest Forecast 65.22 | Highest Forecast 79.55 | Target Price 71.67 |
ANI |
It's important to approach ANI Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize ANI Pharmaceuticals price targets
ANI Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using ANI Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at ANI Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ANI Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional ANI Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ANI Pharmaceuticals is a key component of ANI Pharmaceuticals valuation and have some predictive power on the future returns of a ANI Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested over 200 shares | |
 | Cash Cows Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Momentum Invested over 50 shares | |
 | Robots And Drones Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Defense Sold few shares | |
 | Cars Invested few shares | |
 | Manufacturing Invested over 30 shares | |
 | FinTech Invested over 40 shares | |
 | Business Services Invested few shares |
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.